Neoadjuvant radiotherapy and capecitabine with or without panitumumab in patients with advanced, K-ras unmutated rectal cancer. A randomized multicenter phase II trial To assess the efficacy and safety of the neoadjuvant regimen of capecitabine and external beam radiotherapy in combination with panitumumab in patients with advanced K-ras unmutated rectal cancer.

• Country None
• organs None
• Specialty None

Adjuvant aspirin treatment in PIK3CA mutated colon cancer patients PIK3CA mutációs vastagbélrákban szenvedő betegek kiegészítő aszpirin kezelése The objective of the trial is to demonstrate a statistically significant and clinically relevant disease free survival benefit in stage II and III PIK3CA mutated colon cancer patients taking daily adj...

• Country None
• organs None
• Specialty None

Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced, K-ras mutated rectal cancer. A randomized multicenter phase I/II trial Part I: to determine the recommended dose of the neoadjuvant regimen of capecitabine, sorafenib and external beam radiotherapy in patients with advanced K-ras mutated rectal cancer. Part IIa: to asses...

• Country None
• organs None
• Specialty None